ArticleCPT: pharmacometrics & systems pharmacology2023

Model-based simulation to support the approval of isatuximab alone or with dexamethasone for the treatment of relapsed/refractory multiple myeloma in Japanese patients.

Hoai-Thu Thai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.